Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 3Neoplasms 2Skin Neoplasms 1Pancreatic Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hepatitis C, Chronic 1Hepatitis B, Chronic 1Colonic Neoplasms 1

Interventions

entecavir 2peginterferon alfa-2b 1peginterferon alfa-2a 1ibrutinib 1Tenofovir 1Nucleosides 1Interferons 1Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hepatitis B, Chronic × peginterferon alfa-2a × Clear all
NCT03253250 2017-09-08

The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection

Huashan Hospital

Phase 4 Unknown
432 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡